EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility

Merima Šabanović iD, Alberto Lazari, Marta Blanco-Pozo, Cristiana Tisca, Mohamed Tachrount, Aurea B Martins-Bach, Jason P Lerch, Mark E Walton iD, David M Bannerman iD

Molecular Psychiatry · 2024

DOI: 10.1038/s41380-024-02439-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Psychiatry, 2024. Verfasst von Merima Šabanović und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Psychology, University of Oxford, OX1 3SR, Oxford, UK. mes4023@med.cornell.edu. Hauptthemen laut MEDLINE: Hallucinogens, Amphetamines, Cognition, Neuronal Plasticity. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust (Wellcome).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychedelic drugs can aid fast and lasting remission from various neuropsychiatric disorders, though the underlying mechanisms remain unclear. Preclinical studies suggest serotonergic psychedelics enhance neuronal plasticity, but whether neuroplastic changes can also be seen at cognitive and behavioural levels is unexplored. Here we show that a single dose of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) affects structural brain plasticity and cognitive flexibility in young adult mice beyond the acute drug experience. Using ex vivo magnetic resonance imaging, we show increased volumes of several sensory and association areas one day after systemic administration of 2 mgkg −1 (±)-DOI. We then demonstrate lasting effects of (±)-DOI on cognitive flexibility in a two-step probabilistic reversal learning task where 2 mgkg −1 (±)-DOI improved the rate of adaptation to a novel reversal in task structure occurring one-week post-treatment. Strikingly, (±)-DOI-treated mice started learning from reward omissions, a unique strategy not typically seen in mice in this task, suggesting heightened sensitivity to previously overlooked cues. Crucially, further experiments revealed that (±)-DOI’s effects on cognitive flexibility were contingent on the timing between drug treatment and the novel reversal, as well as on the nature of the intervening experience. (±)-DOI’s facilitation of both cognitive adaptation and novel thinking strategies may contribute to the clinical benefits of psychedelic-assisted therapy, particularly in cases of perseverative behaviours and a resistance to change seen in depression, anxiety, or addiction. Furthermore, our findings highlight the crucial role of time-dependent neuroplasticity and the influence of experiential factors in shaping the therapeutic potential of psychedelic interventions for impaired cognitive flexibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensAmphetaminesCognitionNeuronal PlasticityReversal LearningAnimalsMiceMaleBrainMagnetic Resonance ImagingMice, Inbred C57BLReward

Substanzen

HallucinogensAmphetamines4-iodo-2,5-dimethoxyphenylisopropylamine

Autor:innen und Institutionen

  • Department of Experimental Psychology, University of Oxford, OX1 3SR, Oxford, UK. mes4023@med.cornell.edu.
  • Department of Psychiatry, Weill Cornell Medicine, New York, NY, 10065, USA. mes4023@med.cornell.edu.
  • Wellcome Centre for Integrative Neuroimaging, University of Oxford, OX3 9DU, Oxford, UK.
  • Department of Experimental Psychology, University of Oxford, OX1 3SR, Oxford, UK.
  • Department of Biology, Stanford University, Stanford, CA, 94305, USA.
  • Department of Experimental Psychology, University of Oxford, OX1 3SR, Oxford, UK. mark.walton@psy.ox.ac.uk.

ORCID-Profile: Merima Šabanović, Mark E Walton, David M Bannerman

Förderung

  • Wellcome Trust (Wellcome)

Zitieren

APA

Šabanović, M., Lazari, A., Blanco-Pozo, M., Tisca, C., Tachrount, M., Martins-Bach, A. B., Lerch, J. P., Walton, M. E., & Bannerman, D. M. (2024). Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility. Molecular Psychiatry. https://doi.org/10.1038/s41380-024-02439-2

Vancouver

Šabanović M, Lazari A, Blanco-Pozo M, Tisca C, Tachrount M, Martins-Bach AB, et al. Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility. Molecular Psychiatry. 2024. doi:10.1038/s41380-024-02439-2

BibTeX
@article{abanovi2024,
  author = {Šabanović, Merima and Lazari, Alberto and Blanco-Pozo, Marta and Tisca, Cristiana and Tachrount, Mohamed and Martins-Bach, Aurea B and Lerch, Jason P and Walton, Mark E and Bannerman, David M},
  title = {Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility},
  journal = {Molecular Psychiatry},
  year = {2024},
  doi = {10.1038/s41380-024-02439-2}
}
Kostenlos starten →